Le Lézard
Classified in: Health
Subject: FDA

Blood Flow Monitoring Device - FlowMet-R Gets FDA 510K Clearance


IRVINE, Calif., Oct. 2, 2019 /PRNewswire/ -- Laser Associated Sciences (LAS), a medical device company based in Irvine, California, announced that its blood flow monitoring system, FlowMet-R, received its 510(k) clearance from the Food and Drug Administration (FDA). This clearance allows LAS to market and sell the FlowMet-R. The non-invasive portable device addresses a critical unmet need for vascular specialists who are seeking improved methods to detect and measure treatment efficacy for peripheral artery disease (PAD). The condition, which according to the American Heart Association, affects over 200 million people worldwide, often goes undiagnosed and when left untreated, can result in amputation.

The FlowMet-R is simple for clinicians to use as the device is compact and clips directly onto a patient's toe. The technology includes a small laser diode and a camera the size of a postage stamp to measure blood flow in the digit in real time. This measurement reflects the severity of vascular disease upstream of the digit. Vascular clinicians who use FlowMet-R believe it fills an essential need via intraprocedural monitoring, enabling them to make better decisions about their treatment during surgery.

"By directly measuring limb perfusion during surgeries, physicians can see for the first time whether peripheral blood flow in being improved in real time. This reduces the ambiguity that clinicians currently face in knowing not only if an intervention is effective, but how effective it is. It is inspiring for us to receive such positive feedback from both the medical community and receive clearance from the FDA so quickly," says Sean White, CEO of LAS. 

The company also recently completed a clinical study in which FlowMet-R measurements demonstrated improved accuracy in detecting advanced vascular disease compared to standard vascular assessments. "The results were very impactful toward improving patient care, and we look forward to publishing the results shortly," adds White.

LAS continues to collaborate with clinicians to develop new technologies that will improve outcomes for patients. The company is also exploring opportunities to build products for home use as well.

About Laser Associated Sciences

Laser Associated Sciences is a medical device company based in Irvine, California. The company's mission is to provide users with critical and impactful information by developing optical biometric sensors and non-invasive medical devices for healthcare applications. In addition to selling and marketing its flagship product, FlowMet-R, LAS is developing additional innovative solutions for the medical community and consumers.  

Contact:
Samantha McDermott
224085@email4pr.com 
(760) 671-0071

SOURCE Laser Associated Sciences


These press releases may also interest you

at 08:15
Facedrive Inc. ("Facedrive") , Canada's "people-and-planet first" business and leading tech developer on the forefront of the COVID-19 pandemic, is pleased to announce Facedrive Health's newly launched COVID-19 contact tracing solution, TraceSCAN...

at 08:15
Pear Therapeutics, Inc. ("Pear" or the "Company") today announced that it closed a credit facility for up to $50 million from Perceptive Advisors ("Perceptive"), a leading life sciences investment firm. In connection with the financing, Pear issued...

at 08:15
Reven Holdings, Inc. ("Reven"), a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral illnesses?including COVID-19?and inflammatory...

at 08:13
Trulieve Cannabis Corp ("Trulieve" or the "Company"), a leading and top-performing cannabis company in the United States, today announces the launch of a new product to further extend its variety of quality cannabis offerings for Florida patients....

at 08:11
Americord Registry, the nation's fastest-growing cord blood bank, announced today that it will be distributing tens of thousands of additional surgical face masks, as well as informational pieces about COVID-19, to obstetric practitioners and their...

at 08:10
Aldeyra Therapeutics, Inc. (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases, today announced development plans to...



News published on 2 october 2019 at 08:12 and distributed by: